Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 66 clinical trials
Scopolamine in Bipolar Depression

IV Scopolamine, compared to placebo, in reducing severity of depression in individuals with bipolar disorder who are experiencing a depressive episode of at least moderate severity

  • 0 views
  • 16 May, 2021
  • 1 location
Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation Study

clinical, imaging, EEG, and molecular data across 8 sites to predict treatment outcome for patients experiencing a major depressive episode (MDE).

fluoxetine
citalopram
antidepressants
psychotropic drugs
depression
  • 35 views
  • 03 May, 2021
  • 6 locations
Behavioral Activation Teletherapy to Increase Physical Activity

This is a pilot study of acceptability, feasibility, and preliminary efficacy of a brief, 10-session Behavioral Activation intervention delivered via teletherapy to increase physical activity and treat depressive symptoms.

depressive symptoms
depressed mood
  • 10 views
  • 02 Sep, 2021
  • 1 location
Can the Affects Conveyed by Baroque Music Reduce Anxiety in Patients With Major Depressive Disorder ?

Major depressive disorder, or characterized depressive episode, is a common illness that limits psychosocial functioning and impairs quality of life. The initial goal of treatment for a major

  • 0 views
  • 05 Sep, 2021
  • 1 location
Ketamine as an Adjunctive Therapy for Major Depression (2)

Pragmatic, randomised, controlled, parallel-group, superiority trial of ketamine vs. midazolam as an adjunctive therapy for depression. The main purpose of the trial is to assess the mood-rating score difference between ketamine and midazolam from before the first infusion to 24 hours after the final infusion, supplemented by a 95% confidence …

ketamine
depressed mood
depressive episode
depressive disorder
depression
  • 0 views
  • 09 Sep, 2021
  • 1 location
Study Pilot - Hybrid EEG/fMRI Neurofeedback in Depressed Patients

Cognitive impairment is a common residual symptom after a depressive episode and expose patients to a risk of relapsing or therapeutic resistance. Neurofeedback (using

depressed mood
antidepressants
depressive episode
  • 0 views
  • 26 Jan, 2021
  • 1 location
A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive Medication

This study is open to adults between 18 and 65 years of age who have depression (major depressive disorder). People with a current depressive episode lasting between 2 months and one and a half

  • 0 views
  • 15 Sep, 2021
  • 3 locations
An 18-Month Psychotherapy of Borderline Personality Disorder

criteria for BPD. The investigators are excluding patients who meet the following criteria: psychotic disorders a current major depressive episode bipolar I

antisocial personality disorder
psychotherapy
psychotropic drugs
substance dependence
MRI
  • 1704 views
  • 27 Jan, 2021
  • 1 location
Effectiveness of the First French Psychoeducational Program on Unipolar Depression

leading cause of disability in high-income countries. Notably, among patients with a previous experience of a major depressive episode, it was indeed estimated that up to 85% of those patients will suffer

  • 0 views
  • 26 Jan, 2021
  • 1 location
The Effect of Celecoxib on Neuroinflammation in MDD

found that MDD patients in a current major depressive episode (MDE) had significantly higher TSPO binding in the prefrontal cortex (PFC), anterior cingulate cortex (ACC) and insula, relative to healthy

  • 0 views
  • 10 Jun, 2021
  • 1 location